Latest ISRG news

Intuitive Surgical vs. Stryker: Which MedTech Stock Is the Better Buy Now?

Zacks Investment Research · Wed, 23 Sep 2026 12:35:57 -0400

ISRG's rapid procedure growth, expanding robotics ecosystem and recurring revenues highlight its growth path amid MedTech shifts.

2 Beaten-Down Stocks to Buy Before They Bounce Back

The Motley Fool · Tue, 22 Sep 2026 18:33:01 -0400

Shopify could perform well in the long run by leveraging AI to improve its services. Despite an increasingly competitive landscape, Intuitive Surgical has a strong competitive edge and a large addressable market.

Abbott Laboratories vs. Intuitive Surgical: Recent Quarterly Revenue Trends Reveal a Classic Investing Truth

The Motley Fool · Mon, 21 Sep 2026 15:07:01 -0400

Abbott Laboratories (ABT +0.54%) primarily generates its revenue by researching, developing, manufacturing, and distributing a diverse portfolio of medical devices, diagnostic test systems, nutritional formulas, and generic pharmaceutical products across international healthcare networks.

Ambulatory Surgery Centers Are Becoming ISRG's New Growth Engine

Zacks Investment Research · Mon, 21 Sep 2026 13:11:00 -0400

Intuitive Surgical is expanding robotic surgery in ASCs with lower-cost XiR systems, opening access to new customers and outpatient procedures.

ISRG Wins EU Nod to Expand da Vinci SP in Gynecologic Procedures

Zacks Investment Research · Wed, 16 Sep 2026 12:41:02 -0400

Intuitive Surgical's CE mark expands da Vinci SP into transvaginal gynecology in Europe, opening a new women's health opportunity and growth runway.

Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know

Zacks Investment Research · Wed, 16 Sep 2026 10:01:12 -0400

Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.

ISRG's da Vinci Study Shows Better Outcomes Across 13 Common Conditions

Zacks Investment Research · Tue, 15 Sep 2026 12:10:55 -0400

Intuitive Surgical's da Vinci meta-analysis across 14 million procedures found better perioperative outcomes versus laparoscopic and open surgery.

Market information is provided for research and visualization and is not investment advice.